— Know what they know.
Not Investment Advice

LVTX NASDAQ

LAVA Therapeutics N.V.
1W: +0.0% 1M: +8.1% 3M: +10.8% 1Y: +8.1% 3Y: -69.5%
$1.74
Last traded 2025-11-28 — delisted
NASDAQ · Healthcare · Biotechnology · $45.8M mcap · 12M float · 2.81% daily turnover · Short 28% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
33.1 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 63.1%
Cost Advantage ★
41
Intangibles
33
Switching Cost
36
Network Effect
24
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LVTX has No discernible competitive edge (33.1/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 63.1% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 4Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-08-05 Jefferies — $6 $2 -4 -0.7% $1.51
2024-06-28 H.C. Wainwright Arthur He Initiated $6 — +219.1% $1.88
2024-03-20 Jefferies Roger Song Initiated $6 — +95.4% $3.07

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
7
Earnings Quality
58
Growth
41
Value
29
Momentum
45
Safety
0
Cash Flow
41

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.80
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
-2.52
Bankruptcy prob: 7.4%
Low Risk
Credit Rating
BB-
Score: 37.4/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 1.36x
Accruals: 12.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LVTX scores -4.80, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LVTX scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LVTX's implied 7.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LVTX receives an estimated rating of BB- (score: 37.4/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.42x
PEG
-0.18x
P/S
0.00x
P/B
3.69x
P/FCF
-1.33x
P/OCF
—
EV/EBITDA
0.35x
EV/Revenue
-1.54x
EV/EBIT
0.35x
EV/FCF
0.24x
Earnings Yield
-55.47%
FCF Yield
-75.46%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LVTX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.030
NI / EBT
×
Interest Burden
1.024
EBT / EBIT
×
EBIT Margin
-4.423
EBIT / Rev
×
Asset Turnover
0.074
Rev / Assets
×
Equity Multiplier
2.961
Assets / Equity
=
ROE
-101.9%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LVTX's ROE of -101.9% is driven by Asset Turnover (0.074), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.03 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1176 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.74
Median 1Y
$0.72
5th Pctile
$0.16
95th Pctile
$3.36
Ann. Volatility
95.6%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
ROE -14.8% -20.3% -23.3% -36.3% -27.3% -28.6% -20.9% -31.2% -39.2% -51.4% -68.4% -61.2% -45.5% -45.4% -63.3% -63.8% -73.4% -90.4% -1.0% -1.02%
ROA -12.2% -17.4% -19.8% -30.8% -22.7% -24.0% -15.5% -22.6% -27.2% -34.2% -38.6% -34.2% -24.4% -22.6% -28.5% -27.6% -32.9% -37.1% -34.4% -34.41%
ROIC 73.1% 1.9% 2.6% 3.5% 2.6% 2.6% -5.7% 66.5% 68.9% 76.3% 88.8% 89.7% 66.4% 57.7% 56.2% 54.1% 69.0% 72.5% 63.1% 63.08%
ROCE -13.6% -17.8% -21.5% -34.2% -30.9% -40.1% -24.8% -28.7% -33.7% -40.1% -54.6% -47.8% -32.9% -29.3% -34.4% -36.6% -42.3% -47.6% -46.3% -46.28%
Gross Margin -17.7% -3.5% -2.2% -5.2% 1.0% 1.0% 1.0% 1.0% 24.0% 53.5% 81.1% 56.4% 1.0% — — -3.9% — — — —
Operating Margin -19.4% -6.1% -4.0% -8.8% -10.5% -23.7% -10.3% -4.3% -11.1% -2.6% -202.4% -15.4% -29.1% — — -1.4% — — — —
Net Margin -19.7% -7.4% -3.3% -7.7% -9.6% -17.3% 6.1% -5.6% -11.4% -2.5% -166.7% -18.4% -8.7% — — -79.6% — — — —
EBITDA Margin -19.4% -6.0% -4.0% -8.7% -10.3% -23.3% -9.2% -4.3% -10.8% -2.6% -196.4% -9.3% -3.8% — — -62.3% — — — —
FCF Margin -4.7% -6.3% -5.2% -5.6% -6.2% -7.3% -2.2% 7.8% 3.2% -12.1% 47.3% -5.9% -2.6% -3.7% -3.9% -1.6% -6.0% -7.1% -6.3% -6.35%
OCF Margin -4.5% -6.3% -5.1% -5.5% -6.0% -7.1% -2.2% 10.8% 7.1% -8.1% 58.3% -5.8% -2.6% -3.7% -3.9% -1.6% -6.0% -7.1% -6.3% -6.35%
ROE 3Y Avg snapshot only -1.20%
ROE 5Y Avg snapshot only -82.05%
ROA 3Y Avg snapshot only -41.15%
ROIC Economic snapshot only -1.85%
Cash ROA snapshot only -61.00%
NOPAT Margin snapshot only -4.67%
Pretax Margin snapshot only -4.53%
R&D / Revenue snapshot only 3.76%
SGA / Revenue snapshot only 3.16%
SBC / Revenue snapshot only 39.36%
Valuation
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
P/E Ratio -19.64 -10.00 -4.40 -3.30 -3.44 -2.30 -4.79 -2.88 -1.21 -1.31 -0.77 -1.01 -3.12 -1.99 -1.61 -1.01 -1.22 -1.25 -1.80 -2.417
P/S Ratio 387.70 133.51 36.55 27.05 21.55 16.35 6.78 4.75 2.23 2.20 4.27 6.25 7.12 6.53 6.07 2.13 6.84 7.12 8.41 0.000
P/B Ratio 2.91 2.03 1.02 1.20 1.05 0.81 1.30 1.07 0.58 0.84 0.71 0.83 1.76 1.13 1.35 0.92 1.32 1.78 3.31 3.690
P/FCF -83.11 -21.02 -7.00 -4.82 -3.47 -2.24 -3.05 61.16 70.33 -18.25 9.03 -1.05 -2.76 -1.78 -1.55 -1.34 -1.14 -1.00 -1.33 -1.325
P/OCF — — — — — — — 43.97 31.49 — 7.32 — — — — — — — — —
EV/EBITDA -12.05 -5.02 0.21 -0.31 0.16 0.77 -1.02 1.04 2.03 1.33 1.24 1.17 -0.03 1.47 1.25 2.06 1.29 0.81 0.35 0.352
EV/Revenue 233.33 62.41 -1.69 2.56 -1.07 -6.41 1.84 -1.83 -3.82 -2.15 -6.60 -6.94 0.06 -4.37 -3.82 -3.82 -6.43 -4.14 -1.54 -1.543
EV/EBIT -12.00 -4.99 0.21 -0.31 0.16 0.76 -1.00 1.02 1.99 1.30 1.21 1.13 -0.03 1.41 1.20 1.99 1.25 0.79 0.35 0.349
EV/FCF -50.02 -9.83 0.32 -0.46 0.17 0.88 -0.83 -23.53 -120.57 17.81 -13.96 1.17 -0.02 1.19 0.98 2.39 1.07 0.58 0.24 0.243
Earnings Yield -5.1% -10.0% -22.7% -30.3% -29.1% -43.5% -20.9% -34.7% -82.6% -76.1% -1.3% -99.2% -32.1% -50.2% -62.2% -98.5% -82.1% -79.9% -55.5% -55.47%
FCF Yield -1.2% -4.8% -14.3% -20.7% -28.8% -44.6% -32.8% 1.6% 1.4% -5.5% 11.1% -95.2% -36.2% -56.3% -64.5% -74.8% -87.5% -99.8% -75.5% -75.46%
Price/Tangible Book snapshot only 3.308
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Current Ratio 8.44 11.56 11.42 12.14 7.75 6.74 8.25 6.40 5.54 5.31 5.20 6.62 7.42 6.39 5.36 4.40 6.73 10.78 12.27 12.268
Quick Ratio 8.44 11.56 11.23 12.14 7.75 6.74 8.25 6.40 5.54 5.31 5.20 6.62 7.42 6.39 5.36 4.40 6.73 10.78 12.27 12.268
Debt/Equity 0.03 0.03 0.04 0.04 0.05 0.05 0.05 0.06 0.09 0.11 0.11 0.12 0.12 0.14 0.19 0.19 0.01 0.00 0.00 0.000
Net Debt/Equity -1.16 -1.08 -1.07 -1.08 -1.10 -1.13 -0.95 -1.48 -1.57 -1.65 -1.80 -1.74 -1.75 -1.88 -2.20 -2.57 -2.57 -2.82 -3.92 -3.915
Debt/Assets 0.02 0.03 0.03 0.03 0.04 0.04 0.03 0.04 0.05 0.06 0.06 0.06 0.06 0.07 0.08 0.07 0.00 0.00 0.00 0.000
Debt/EBITDA -0.21 -0.17 -0.16 -0.11 -0.15 -0.12 -0.14 -0.16 -0.19 -0.18 -0.13 -0.16 -0.23 -0.28 -0.28 -0.24 -0.01 -0.00 -0.00 -0.000
Net Debt/EBITDA 7.97 5.72 4.68 2.96 3.44 2.72 2.75 3.73 3.22 2.69 2.04 2.22 3.25 3.68 3.24 3.21 2.65 2.20 2.27 2.271
Interest Coverage -150.69 -82.34 -68.40 -86.97 -65.20 -89.81 -129.23 -137.70 -418.50 — — — — — — -44.61 -39.89 -40.64 -34.27 -34.270
Equity Multiplier 1.21 1.17 1.18 1.18 1.19 1.23 1.62 1.67 1.80 1.92 2.03 1.99 1.96 2.15 2.53 2.91 2.76 3.04 4.09 4.093
Cash Ratio snapshot only 11.738
Debt Service Coverage snapshot only -33.952
Defensive Interval snapshot only 1818.9 days
Efficiency & Turnover
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Asset Turnover 0.01 0.01 0.02 0.04 0.04 0.03 0.11 0.14 0.15 0.20 0.07 0.06 0.11 0.07 0.08 0.13 0.06 0.07 0.07 0.074
Inventory Turnover — — 10.55 — — — 4.62 — — — — — — — — — — — — —
Receivables Turnover 2.26 4.87 2.98 14.44 12.18 9.77 0.69 10.72 16.05 10.74 0.35 2.87 9.09 3.23 9.11 16.42 13.54 17.15 18.62 18.619
Payables Turnover 10.88 10.94 15.88 14.47 8.33 5.24 1.37 0.00 0.32 0.83 0.39 0.83 0.78 0.04 0.03 6.85 9.91 8.79 10.88 10.880
DSO 162 75 123 25 30 37 533 34 23 34 1041 127 40 113 40 22 27 21 20 19.6 days
DIO 0 0 35 0 0 0 79 — 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 34 33 23 25 44 70 267 — 1133 440 942 441 469 10269 14457 53 37 42 34 33.5 days
Cash Conversion Cycle 128 42 134 0 -14 -32 344 — -1110 -406 99 -314 -429 -10156 -14417 -31 -10 -20 -14 -13.9 days
Cash Velocity snapshot only 0.100
Capital Intensity snapshot only 10.404
Growth (YoY)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Revenue — — — — 4.3% 1.2% 3.3% 2.7% 2.7% 4.2% -49.2% -65.1% -36.0% -69.5% -18.9% 77.0% -60.2% -32.5% -32.1% -32.06%
Net Income — — — — -67.2% -19.1% 27.4% 25.7% -9.1% -22.8% -99.9% -31.6% 20.5% 40.3% 45.0% 40.0% 2.1% -17.1% 16.0% 15.98%
EPS — — — — -65.6% -17.9% 29.2% 27.1% -7.0% -20.4% -1.0% -29.2% 22.0% 41.5% 46.2% 40.2% 2.4% -16.8% 16.1% 16.14%
FCF — — — — -6.0% -1.6% -81.6% 1.1% 1.0% 91.4% 1.1% -27.8% -53.0% -8.3% -7.7% 52.5% 7.4% -30.4% -10.2% -10.23%
EBITDA — — — — -78.5% -50.6% 6.0% 21.3% -6.5% -0.5% -50.1% -17.7% 26.1% 44.0% 53.5% 44.8% 8.3% -16.5% 2.4% 2.35%
Op. Income — — — — -80.0% -51.8% 4.9% 20.3% -7.6% -1.6% -50.8% -24.2% 15.7% 31.2% 42.9% 31.1% -11.4% -20.5% -4.9% -4.87%
OCF Growth snapshot only -10.29%
Asset Growth snapshot only -37.72%
Equity Growth snapshot only -61.56%
Debt Growth snapshot only -1.00%
Shares Change snapshot only 0.20%
Growth (CAGR)
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Revenue 3Y — — — — — — — — — — — — 1.3% 52.6% 20.7% 31.7% -1.8% 2.4% -34.6% -34.57%
Revenue 5Y — — — — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — -15.1% -16.8% -21.9% -16.6% -18.1% -19.3% -29.8% -29.77%
Assets 5Y — — — — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — -27.6% -32.1% -39.5% -38.3% -38.0% -40.4% -48.5% -48.46%
Book Value 3Y — — — — — — — — — — — — -28.7% -33.2% -40.3% -39.2% -38.9% -41.2% -48.8% -48.75%
Dividend 3Y — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Revenue Stability — — — — — — — — 0.91 0.84 0.12 0.01 0.60 0.21 0.00 0.02 0.02 0.05 0.86 0.859
Earnings Stability — — — — — — — — 0.88 0.99 0.38 0.01 0.29 0.00 0.00 0.43 0.10 0.04 0.09 0.085
Margin Stability — — — — — — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 0.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.96 0.91 0.50 0.87 0.92 0.84 0.82 0.84 0.99 0.93 0.94 0.936
Earnings Smoothness — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.25 -0.36 -0.67 -0.45 -0.17 -0.07 -0.24 -0.31 -0.57 -0.82 -0.95 -0.954
Gross Margin Trend — — — — — — — — 11.04 6.97 3.45 3.01 1.55 1.48 0.35 -1.79 -4.79 -4.84 -4.73 -4.726
FCF Margin Trend — — — — — — — — 5.47 6.70 4.20 -3.18 0.52 0.03 -3.04 1.34 -4.72 -5.21 -4.63 -4.627
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
OCF/Net Income 0.23 0.47 0.61 0.67 0.96 1.00 1.55 -0.07 -0.04 0.05 -0.10 0.94 1.12 1.12 1.04 0.76 1.07 1.25 1.36 1.361
FCF/OCF 1.04 1.01 1.03 1.03 1.03 1.03 1.01 0.72 0.45 1.49 0.81 1.02 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.361
CapEx/Revenue 16.6% 8.0% 14.1% 14.4% 17.3% 20.1% 2.9% 3.2% 4.0% 4.1% 11.0% 10.7% 2.0% 0.0% 0.2% 0.2% 0.0% 0.5% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.09 -0.09 -0.08 -0.10 -0.01 -0.00 0.09 -0.24 -0.28 -0.33 -0.43 -0.02 0.03 0.03 0.01 -0.07 0.02 0.09 0.12 0.124
Sloan Accruals snapshot only -0.279
Dividends & Buybacks
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — 0.0% 0.0% — 0.0% — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — —
Buyback Yield 1.3% 1.9% 3.4% 3.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -22.4% -32.1% -58.3% -62.8% -2.0% 0.0% 0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.00%
Total Shareholder Return -22.4% -32.1% -58.3% -62.8% -2.0% 0.0% 0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.0% 0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.03 1.03 1.03 1.03 1.030
Interest Burden (EBT/EBIT) 1.01 1.07 1.01 0.98 0.94 0.83 0.76 0.91 0.95 1.01 1.02 1.01 1.00 1.05 1.17 1.07 1.06 1.05 1.02 1.024
EBIT Margin -19.44 -12.51 -8.24 -8.34 -6.65 -8.49 -1.84 -1.80 -1.92 -1.65 -5.44 -6.13 -2.26 -3.09 -3.19 -1.92 -5.15 -5.25 -4.42 -4.423
Asset Turnover 0.01 0.01 0.02 0.04 0.04 0.03 0.11 0.14 0.15 0.20 0.07 0.06 0.11 0.07 0.08 0.13 0.06 0.07 0.07 0.074
Equity Multiplier 1.21 1.17 1.18 1.18 1.20 1.19 1.34 1.38 1.44 1.51 1.77 1.79 1.86 2.01 2.22 2.31 2.23 2.43 2.96 2.961
Per Share
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
EPS (Diluted TTM) $-0.77 $-1.09 $-1.35 $-1.67 $-1.28 $-1.28 $-0.95 $-1.21 $-1.37 $-1.55 $-1.92 $-1.57 $-1.07 $-0.90 $-1.03 $-0.94 $-1.04 $-1.06 $-0.87 $-0.87
Book Value/Share $5.23 $5.37 $5.79 $4.59 $4.21 $3.65 $3.50 $3.27 $2.86 $2.43 $2.08 $1.91 $1.89 $1.60 $1.23 $1.03 $0.96 $0.74 $0.47 $0.47
Tangible Book/Share $5.23 $5.37 $5.53 $4.59 $4.21 $3.65 $3.50 $3.27 $2.86 $2.43 $2.08 $1.91 $1.89 $1.60 $1.23 $1.03 $0.96 $0.74 $0.47 $0.47
Revenue/Share $0.04 $0.08 $0.16 $0.20 $0.20 $0.18 $0.67 $0.74 $0.75 $0.92 $0.34 $0.25 $0.47 $0.28 $0.27 $0.45 $0.19 $0.19 $0.19 $0.00
FCF/Share $-0.18 $-0.52 $-0.85 $-1.14 $-1.27 $-1.31 $-1.50 $0.06 $0.02 $-0.11 $0.16 $-1.50 $-1.20 $-1.01 $-1.07 $-0.71 $-1.11 $-1.32 $-1.18 $-1.13
OCF/Share $-0.18 $-0.51 $-0.82 $-1.11 $-1.23 $-1.28 $-1.48 $0.08 $0.05 $-0.07 $0.20 $-1.48 $-1.20 $-1.01 $-1.07 $-0.71 $-1.11 $-1.32 $-1.18 $-1.13
Cash/Share $6.20 $5.96 $6.41 $5.17 $4.82 $4.29 $3.51 $5.05 $4.77 $4.28 $3.98 $3.57 $3.53 $3.24 $2.94 $2.85 $2.47 $2.09 $1.85 $1.85
EBITDA/Share $-0.76 $-1.01 $-1.32 $-1.68 $-1.34 $-1.51 $-1.21 $-1.30 $-1.40 $-1.49 $-1.83 $-1.50 $-1.02 $-0.82 $-0.83 $-0.83 $-0.93 $-0.95 $-0.81 $-0.81
Debt/Share $0.16 $0.17 $0.21 $0.19 $0.20 $0.19 $0.18 $0.21 $0.27 $0.26 $0.24 $0.24 $0.23 $0.23 $0.23 $0.20 $0.01 $0.00 $0.00 $0.00
Net Debt/Share $-6.05 $-5.79 $-6.19 $-4.98 $-4.62 $-4.11 $-3.33 $-4.85 $-4.51 $-4.01 $-3.74 $-3.33 $-3.30 $-3.01 $-2.70 $-2.65 $-2.46 $-2.09 $-1.85 $-1.85
Academic Models
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — -4.802
Altman Z-Prime snapshot only -7.909
Piotroski F-Score 2 2 2 2 3 3 4 5 3 2 3 2 3 2 2 3 1 2 2 2
Beneish M-Score — — — — -12.30 -3.97 4.59 -4.72 -0.95 5.07 -44.91 -1.25 0.40 — — 7.17 — — — —
Ohlson O-Score snapshot only -2.521
ROIC (Greenblatt) snapshot only -46.29%
Net-Net WC snapshot only $0.47
Credit
Metric Trend Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Current
Credit Rating snapshot only BB-
Credit Score 59.62 59.60 53.30 54.35 47.44 37.61 38.28 45.42 37.55 44.06 52.14 44.66 44.52 44.23 44.45 32.63 32.77 37.64 37.40 37.402
Credit Grade snapshot only 13
Credit Trend snapshot only -7.044
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 32
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms